Iradimed (IRMD) Net Income Growth (3y) (2016 - 2026)
Iradimed (IRMD) Net Income Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.01 Bn | 175.72 Bn | 6.27 Bn | -6.51% |
| 2 | Stryker | 128.76 Bn | 125.88 Bn | 3.81 Bn | 7.96% |
| 3 | Medtronic | 108.90 Bn | 99.68 Bn | 6.41 Bn | 1.93% |
| 4 | Boston Scientific | 68.43 Bn | 66.98 Bn | 3.61 Bn | 62.29% |
| 5 | Edwards Lifesciences | 47.96 Bn | 44.29 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 28.29 Bn | 26.01 Bn | 1.98 Bn | 2.38% |
| 7 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 60.12% |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 25.44 Bn | 22.31 Bn | 2.07 Bn | 280.49% |
| 10 | Iradimed | 1.22 Bn | 1.16 Bn | 16.81 Mn | 19.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.54% |
| Dec 31, 2025 | 19.43% |
| Sep 30, 2025 | 17.62% |
| Jun 30, 2025 | 21.23% |
| Mar 31, 2025 | 23.53% |
| Dec 31, 2024 | 0.46% |
| Sep 30, 2024 | 25.15% |
| Jun 30, 2024 | 49.40% |
| Mar 31, 2024 | 43.95% |
| Dec 31, 2023 | 44.82% |
| Sep 30, 2023 | 67.69% |
| Jun 30, 2023 | 58.46% |
| Mar 31, 2023 | 24.40% |
| Dec 31, 2022 | 4.86% |
| Sep 30, 2022 | 11.76% |
| Jun 30, 2022 | 15.77% |
| Mar 31, 2022 | 10.45% |
| Dec 31, 2021 | 36.98% |
| Sep 30, 2021 | 2.39% |
| Jun 30, 2021 | 2.75% |